Loratadine D Tablet, Film Coated, Extended Release
Product Images NDC 45802-122

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Loratadine D (NDC 45802-122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Packaging label for Loratadine-D 12 Hour Extended Release Tablets containing Pseudoephedrine Sulfate 120 mg and Loratadine 5 mg. The label describes the product as a nasal decongestant and antihistamine for relief of nasal and sinus congestion, sneezing, runny nose, itchy watery eyes, and itchy throat or nose due to allergies. The box holds 20 tablets and is labeled by Perrigo, including a comparison to Claritin-D 12 Hour. A tablet image is shown at actual size.*

FDA Label Image

Image 02

Drug Facts panel for loratadine D tablets, film-coated extended release, containing loratadine 5 mg and pseudoephedrine sulfate 120 mg. The panel lists active ingredients, uses for allergy and congestion relief, warnings including allergy and medical conditions, directions for use, and inactive ingredients. Distributed by Perrigo. Includes storage instructions and contact information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.